Rocuronium Bromide Injection, 50 Mg/5 Ml Rbc 50 mg/5 mL RBC Solution for Injection
PDF Leaflet Revision Date: 23 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to general anaesthesia for tracheal intubation and muscle relaxation.
Dosage (summary)
Intubation: 0.6 mg/kg (routine), 1 mg/kg (rapid sequence). Maintenance: 0.15 mg/kg.
Onset of Action / Duration
Onset: 60-90 secs, Duration: 30-50 mins.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
- Obese patients
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Halogenated volatile anaesthetics
- Aminoglycoside antibiotics
- Corticosteroids
Contraindications
- Hypersensitivity to rocuronium or bromide
- Neonates
Common side effects
- Injection site pain
- Tachycardia
- Prolonged neuromuscular block
Counselling Points
- Monitor for respiratory function post-administration.
- Inform about potential allergic reactions.
- Advise on the importance of neuromuscular monitoring.
Serious warnings
- Respiratory paralysis requires ventilatory support.
- Risk of residual neuromuscular blockade.
- Cross-sensitivity with other neuromuscular blockers.
Important Disclaimer
The Rocuronium Bromide Injection, 50 Mg/5 Ml Rbc 50 mg/5 mL RBC Solution for Injection professional information leaflet below is the property of Rbc Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
